BiPER THERAPEUTICS
- Biotech or pharma, therapeutic R&D
First-In-Class therapeutics overstressing pathological cells to cure patients. Our lead clinical candidate is a first-in-class selective BiP inhibitor to treat the >50% BiP-positive cancer patients without solutions
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}